Skip to main content
Log in

Eltrombopag for radiation-induced thrombocytopenia in a glioblastoma patient

  • Letter to the Editor
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Corman SL, Mohammad RA (2010) Eltrombopag: a novel oral thrombopoietin receptor agonist. Ann Pharmacother 44(6):1072–1079

    Article  PubMed  CAS  Google Scholar 

  2. Kellum A et al (2010) A randomized, double-blind, placebo-controlled, dose ranging study to assess the efficacy and safety of eltrombopag in patients receiving carboplatin/paclitaxel for advanced solid tumors. Curr Med Res Opin 26(10):2339–2346

    Article  PubMed  CAS  Google Scholar 

  3. Jenkins JM et al (2007) Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist. Blood 109(11):4739–4741

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Santosh Kesari.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Duic, J.P., Grewal, J., McConie, K. et al. Eltrombopag for radiation-induced thrombocytopenia in a glioblastoma patient. J Neurooncol 106, 427–429 (2012). https://doi.org/10.1007/s11060-011-0675-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-011-0675-5

Keywords

Navigation